Detalles de la búsqueda
1.
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma.
Blood;
128(19): 2297-2306, 2016 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27647864
2.
Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands.
Haematologica;
99(2): 339-45, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24038025
3.
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study.
BMC Cancer;
14: 219, 2014 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24661373
4.
Future steps in cardio-oncology-a national multidisciplinary survey among healthcare professionals in the Netherlands.
J Cancer Surviv;
17(4): 1131-1138, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35118579
5.
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.
J Clin Oncol;
41(1): 86-95, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947813
6.
IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
Blood Adv;
6(7): 2254-2266, 2022 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086136
7.
Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands.
Breast J;
17(3): 239-45, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21477166
8.
Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.
PLoS One;
16(3): e0249067, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788897
9.
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
J Natl Cancer Inst;
113(6): 760-769, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351090
10.
Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial.
Cancers (Basel);
13(19)2021 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638428
11.
Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting.
Haematologica;
95(9): 1503-9, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20494934
12.
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer.
Nat Commun;
11(1): 525, 2020 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31988276
13.
Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes.
JMIR Res Protoc;
8(5): e12453, 2019 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31045506
14.
Towards an evidence-based model of fear of cancer recurrence for breast cancer survivors.
J Cancer Surviv;
11(1): 41-47, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27412726
15.
Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.
Eur J Cancer;
52: 67-76, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26650831
16.
Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.
PLoS One;
10(4): e0120823, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25831053
17.
The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.
Acta Oncol;
48(6): 927-31, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19452305
18.
Successful centralisation of patients with vulvar carcinoma: a population-based study in The Netherlands.
Eur J Cancer;
48(13): 1997-2003, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22387182
19.
Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands.
Autoimmun Rev;
10(4): 228-34, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21074639
20.
Improving relative survival, but large remaining differences in survival for non-Hodgkin's lymphoma across Europe and the United States from 1990 to 2004.
J Clin Oncol;
29(2): 192-9, 2011 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21115853